Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $2.502B (100.0% shares, 0.0% debt)

Holdings (36)

— ABIOMED INC 14.6%
Value $364M Shares 890,309 Share Price $409.05 Est. Cost/Share $32.04 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 9.6%
Value $240M Shares 2,549,431 Share Price $94.20 * Est. Cost/Share $79.79 Unrealized @ Report Date +9.8%
— CLOVIS ONCOLOGY INC 9.0%
Value $226M Shares 4,974,007 Share Price $45.47 Est. Cost/Share $52.39 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP DEL 7.3%
Value $184M Shares 1,625,234 Share Price $113.15 * Est. Cost/Share $88.73 Unrealized @ Report Date +23.9%
INSM INSMED INC 6.8%
Value $171M Shares 7,236,583 Share Price $23.65 * Est. Cost/Share $16.77 Unrealized @ Report Date +53.5%
— ALEXION PHARMACEUTICALS INC 5.9%
Value $147M Shares 1,186,427 Share Price $124.15 Est. Cost/Share $121.06 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 5.2%
Value $130M Shares 832,536 Share Price $156.53 Est. Cost/Share $48.02 Unrealized @ Report Date —
— IMMUNOMEDICS INC 4.5%
Value $114M Shares 4,803,364 Share Price $23.67 Est. Cost/Share $11.54 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 4.4%
Value $109M Shares 3,521,565 Share Price $31.00 * Est. Cost/Share $8.00 Unrealized @ Report Date +192.4%
FOLD AMICUS THERAPEUTICS INC 3.9%
Value $96.35M Shares 6,168,347 Share Price $15.62 * Est. Cost/Share $6.44 Unrealized @ Report Date +134.7%
— EPIZYME INC 3.7%
Value $93.58M Shares 6,906,158 Share Price $13.55 Est. Cost/Share $15.12 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 3.2%
Value $79.23M Shares 4,663,324 Share Price $16.99 Est. Cost/Share $18.85 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 3.2%
Value $79.17M Shares 4,155,670 Share Price $19.05 * Est. Cost/Share $8.70 Unrealized @ Report Date +92.1%
— WRIGHT MED GROUP N V 2.9%
Value $71.59M Shares 2,757,587 Share Price $25.96 Est. Cost/Share $23.42 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 2.6%
Value $65.15M Shares 3,340,806 Share Price $19.50 Est. Cost/Share $29.37 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 2.5%
Value $63.16M Shares 184,607 Share Price $342.14 * Est. Cost/Share $98.66 Unrealized @ Report Date +202.4%
— MOMENTA PHARMACEUTICALS INC 1.5%
Value $37.5M Shares 1,833,532 Share Price $20.45 Est. Cost/Share $14.12 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 1.5%
Value $37.16M Shares 1,381,759 Share Price $26.89 Est. Cost/Share $23.79 Unrealized @ Report Date —
— SHIRE PLC 1.3%
Value $32.27M Shares 191,200 Share Price $168.80 Est. Cost/Share $197.13 Unrealized @ Report Date —
— CELGENE CORP 1.3%
Value $31.36M Shares 394,840 Share Price $79.42 Est. Cost/Share $95.51 Unrealized @ Report Date —
— ALDER BIOPHARMACEUTICALS INC 1.2%
Value $29.28M Shares 1,853,101 Share Price $15.80 Est. Cost/Share $11.48 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 1.0%
Value $25.21M Shares 1,650,780 Share Price $15.27 * Est. Cost/Share $29.82 Unrealized @ Report Date -40.2%
EXAS EXACT SCIENCES CORP 0.7%
Value $18.73M Shares 313,320 Share Price $59.79 * Est. Cost/Share $13.61 Unrealized @ Report Date +295.3%
PRTA PROTHENA CORP PLC 0.6%
Value $16.09M Shares 1,103,325 Share Price $14.58 * Est. Cost/Share $32.98 Unrealized @ Report Date -40.1%
GILD GILEAD SCIENCES INC 0.5%
Value $12.46M Shares 175,900 Share Price $70.84 * Est. Cost/Share $62.02 Unrealized @ Report Date -15.0%
— RIGEL PHARMACEUTICALS INC 0.4%
Value $11.22M Shares 3,966,087 Share Price $2.83 Est. Cost/Share $3.40 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.2%
Value $6.136M Shares 500,913 Share Price $12.25 Est. Cost/Share $5.39 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $2.948M Shares 3,013,793 Share Price $0.98 Est. Cost/Share $4.88 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.1%
Value $2.464M Shares 1,162,473 Share Price $2.12 Est. Cost/Share $4.37 Unrealized @ Report Date —
— ZOGENIX INC 0.1%
Value $1.304M Shares 29,500 Share Price $44.20 Est. Cost/Share $13.36 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.0%
Value $1.027M Shares 123,686 Share Price $8.30 Est. Cost/Share $6.71 Unrealized @ Report Date +24.0%
— IDERA PHARMACEUTICALS INC 0.0%
Value $814K Shares 616,355 Share Price $1.32 Est. Cost/Share $3.70 Unrealized @ Report Date —
— HISTOGENICS CORP 0.0%
Value $757K Shares 302,922 Share Price $2.50 Est. Cost/Share $11.00 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $694K Shares 247,000 Share Price $2.81 Est. Cost/Share $2.60 Unrealized @ Report Date —
— TREVENA INC 0.0%
Value $491K Shares 341,300 Share Price $1.44 Est. Cost/Share $2.30 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 0.0%
Value $322K Shares 50,689 Share Price $6.35 Est. Cost/Share $15.80 Unrealized @ Report Date —